CHDArrhythmiasDiabetesLipidologyHeart FailureHypertensionStrokeThrombosis
Log in
Username
Password
Remember me
Content managed by and international Editorial Board, chaired by Professor Desmond Julian
Bookmark this site|Register Me|Forgotten Password
Welcome to InCirculation.net
InCirculation.net is a professional cardiovascular resource intended for a global audience of specialists, generalists, researchers, and other healthcare professionals
Would you like to know what else InCirculation.net has to offer? Take the tour of InCirculation.net
Click here to register

Cardiovascular News



Page summary
Text size
News quick search
Cardiovascular news provides daily news updates to help you stay informed.
 

Direct measurement of cholesterol levels comparable to standard methods


10 March 2010

MedWire News: Direct measurement of both high- and low-density lipoprotein cholesterol (HDL-C and LDL-C) using modern assay techniques reveals similar levels to those found using standard methods, say US researchers.

In the past, a number of issues have made direct measurement of cholesterol values difficult. For example, HDL-C measurement required a manual precipitation step.

The Friedewald formula has been the standard method used to estimate LDL-C levels. However, now that high-throughput, standardized, automated assays are available, Schaefer and co-workers were able to check how closely cholesterol levels calculated using the new techniques correlated with those using the Friedewald formula and HDL-C following manual precipitation.

Ernst Schaefer (Tufts University, Boston, Massachusetts) and co-workers analysed fasting plasma samples from patients from the Framingham Offspring study. Samples from 1508 men (1335 controls, 173 coronary heart disease [CHD] cases) and 1680 women (1606 controls, 74 CHD cases) were included in the analysis.

The researchers found that values for direct LDL-C and HDL-C correlated well with standard methods. They note that the correlation between calculated and direct values for HDL-C is important since direct HDL-C assays are now very widely used and have not previously been evaluated in large-scale populations studies of CHD risk. However, the calculated and direct measurements differed by more than 10% for 7.7% of samples for LDL-C, and for 8.5% of samples for HDL-C.

Another aim of the study was to assess whether patients with CHD had reached the recommended goals for LDL-C (2.6 mmol/l; 100 mg/dl) set by the Adult Treatment Panel of the National Cholesterol Education Program of the National Institutes of Health. However the values for both men (2.99 mmol/l; 115.7 mg/dl Friedewald/ 3.07 mmol/l; 118.8 mg/dl direct) and women (3.33 mmol/l; 128.9 mg/dl Friedewald/3.46 mmol/l; 133.9 mg/dl direct) were well above this target.

Schaefer and co-workers note that despite four-fold greater use of cholesterol-lowering medication in male and female cases versus controls, less than half of cases were receiving such medication.

“Overall, our data indicate that the direct assays for both LDL-C and HDL-C provide an acceptable guide for lipid treatment, and that in this population there is still substantial residual CHD risk and under-treatment of LDL-C values, with a very high percentage of CHD cases not being at the recommended LDL-C targets, especially in women,” they conclude in the journal Atherosclerosis.

MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010

Atherosclerosis 2010; Advance online publication



© Copyright Springer Healthcare Ltd, 2012

Related Content

Congress Reports
AHA 2011

EASD 2011

Your opinion matters – help to shape the future of InCirculation.net by completing our short survey. Click here!

To receive our weekly newsletter, register or update your profile. Click here!
All rights reserved. This website is intended for an international audience. Privacy PolicyLegal NoticeTerms and Conditions